To investigate the molecular mechanism of PTPN3-mediated cisplatin and doxorubicin resistance in ovarian cancer cells, cell cycle analysis was used to examine the effect of silencing PTPN3 on cell signalling pathways. Here, PTPN3 is linked to ovarian cancer.